
CAPR
Healthcare · Biotechnology · $554.1M market cap
$9.53-0.71 (-6.9%)Nov 13, 4:19 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -114.4% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 10, 2026 | After the close | -0.61 | -0.73 | -19.7% |
| Aug 13, 2026 | After the close | -0.58 | -0.70 | -20.7% |
| May 20, 2026 | Time not confirmed | -0.48 | -0.59 | -23.4% |
| Mar 12, 2026 | After the close | -0.55 | -0.62 | -12.7% |
| Nov 10, 2025 | After the close | -0.54 | -0.54 | 0.0% |
| Aug 11, 2025 | After the close | -0.48 | -0.57 | -18.8% |
| May 13, 2025 | After the close | -0.32 | -0.53 | -65.6% |
| Mar 19, 2025 | Time not confirmed | -0.31 | -0.16 | +48.4% |
| Nov 13, 2024 | After the close | -0.34 | -0.38 | -11.8% |
| Aug 7, 2024 | After the close | -0.33 | -0.35 | -6.1% |
| May 13, 2024 | After the close | -0.11 | -0.31 | -181.8% |
| Feb 29, 2024 | After the close | -0.09 | -0.02 | +77.8% |
| Nov 14, 2023 | After the close | -0.27 |
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is in phase 3 clinical trial for the treatment of DMD. The…
| -0.25 |
| +7.4% |
| Aug 7, 2023 | After the close | -0.33 | -0.29 | +12.1% |
| May 11, 2023 | After the close | -0.32 | -0.31 | +3.1% |
| Mar 15, 2023 | After the close | -0.33 | -0.31 | +6.1% |
| Nov 10, 2022 | After the close | -0.32 | -0.26 | +18.8% |
| Aug 10, 2022 | After the close | -0.25 | -0.29 | -16.0% |
| May 10, 2022 | After the close | -0.32 | -0.32 | 0.0% |
| Mar 10, 2022 | After the close | -0.19 | -0.26 | -36.8% |
| Nov 9, 2021 | After the close | -0.23 | -0.17 | +26.1% |
| Aug 12, 2021 | After the close | -0.23 | -0.21 | +8.7% |
| May 13, 2021 | After the close | -0.23 | -0.23 | 0.0% |
| Mar 11, 2021 | After the close | -0.20 | -0.21 | -5.0% |
| Nov 12, 2020 | After the close | -0.18 | -0.20 | -11.1% |
| Aug 6, 2020 | After the close | -0.34 | -0.23 | +32.4% |
| May 14, 2020 | After the close | -0.33 | -0.30 | +9.1% |
| Mar 18, 2020 | After the close | -0.34 | -0.34 | 0.0% |
| Nov 7, 2019 | After the close | -0.68 | -0.43 | +36.8% |
| Aug 6, 2019 | After the close | -0.80 | -0.59 | +26.3% |
| May 13, 2019 | After the close | -1.10 | -0.80 | +27.3% |
| Mar 28, 2019 | After the close | -1.60 | -1.10 | +31.3% |
| Nov 13, 2018 | After the close | -1.45 | -1.40 | +3.4% |
| Aug 9, 2018 | After the close | -1.25 | -1.40 | -12.0% |
| May 10, 2018 | After the close | -1.20 | -1.40 | -16.7% |
| Mar 14, 2018 | After the close | -1.00 | -1.10 | -10.0% |